- Home
- SSY vs APLM Comparison
SSY vs APLM Comparison
Compare SSY & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- APLM
- Stock Information
- Founded
- SSY 1959
- APLM 2016
- Country
- SSY United States
- APLM United States
- Employees
- SSY N/A
- APLM N/A
- Industry
- SSY Hospital/Nursing Management
- APLM Blank Checks
- Sector
- SSY Health Care
- APLM Finance
- Exchange
- SSY Nasdaq
- APLM Nasdaq
- Market Cap
- SSY 6.2M
- APLM 6.9M
- IPO Year
- SSY N/A
- APLM N/A
- Fundamental
- Price
- SSY $0.88
- APLM $6.41
- Analyst Decision
- SSY
- APLM
- Analyst Count
- SSY 0
- APLM 0
- Target Price
- SSY N/A
- APLM N/A
- AVG Volume (30 Days)
- SSY 192.4K
- APLM 4.6K
- Earning Date
- SSY 05-13-2025
- APLM 08-13-2025
- Dividend Yield
- SSY N/A
- APLM N/A
- EPS Growth
- SSY N/A
- APLM N/A
- EPS
- SSY 0.25
- APLM N/A
- Revenue
- SSY $31,094,000.00
- APLM $198,000.00
- Revenue This Year
- SSY N/A
- APLM $415.15
- Revenue Next Year
- SSY N/A
- APLM N/A
- P/E Ratio
- SSY $3.57
- APLM N/A
- Revenue Growth
- SSY N/A
- APLM N/A
- 52 Week Low
- SSY $0.62
- APLM $4.47
- 52 Week High
- SSY $1.91
- APLM $35.98
- Technical
- Relative Strength Index (RSI)
- SSY 41.55
- APLM 51.61
- Support Level
- SSY $0.95
- APLM $5.34
- Resistance Level
- SSY $1.06
- APLM $6.70
- Average True Range (ATR)
- SSY 0.09
- APLM 0.52
- MACD
- SSY -0.01
- APLM -0.03
- Stochastic Oscillator
- SSY 11.21
- APLM 67.65
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.